| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.011 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |